
Silence Therapeutics (SLN) Earnings Dates & Reports
Silence Therapeutics (SLN) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS-$0.43
Actual EPS-$0.27
EarningsBeat
Silence Therapeutics (SLN) Earnings
View the latest Silence Therapeutics (SLN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Silence Therapeutics (SLN)
Order type
Buy in
Order amount
Est. shares
0 shares
Silence Therapeutics (SLN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Silence Therapeutics (SLN) Latest Earnings
The value each SLN share was expected to gain vs. the value each share gained.
Silence Therapeutics (SLN) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$0.27. This exceeded analysts' expectations of -$0.43 by 37.21%, marking a Beat.
For comparison, Silence Therapeutics reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.34.
Silence Therapeutics (SLN) Earnings History
Silence Therapeutics (SLN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Silence Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — |
Silence Therapeutics (SLN) Earnings FAQs
Silence Therapeutics (SLN) last reported earnings on Mar 11, 2026 for Q4 2025, posting an EPS of -$0.27, which Beat the estimate of -$0.43 by 37.21%.
For Q4 2025, Silence Therapeutics (SLN) reported an EPS of -$0.27, exceeding analysts' estimate of -$0.43 by 37.21%.
For Q4 2025, Silence Therapeutics (SLN) Beat expectations with an actual EPS of -$0.27 vs. an estimated EPS of -$0.43.
Following the last earnings report on Mar 11, 2026, Silence Therapeutics (SLN)'s stock price moved — from — to —.
The next Silence Therapeutics (SLN) earnings call is scheduled for May. 7, 2026, where executives will discuss financial results and outlook.